Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.86+0.31 (+2.29%)
Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –
Integra LifeSciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Integra LifeSciences's operating cash flow for the twelve months ending Sep 30, 2026 was $140.40M, up 57.2% year over year. For fiscal 2025 it was $50.38M, down 61.1% from the year before. Over ten years it grew -7.1% a year on average. The highest annual figure on record is $312.43M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.38M | -61.1% |
| FY2024 | Dec 31, 2024 | $129.38M | -7.6% |
| FY2023 | Dec 31, 2023 | $139.96M | -47.1% |
| FY2022 | Dec 31, 2022 | $264.47M | -15.4% |
| FY2021 | Dec 31, 2021 | $312.43M | +53.3% |
| FY2020 | Dec 31, 2020 | $203.83M | -11.9% |
| FY2019 | Dec 31, 2019 | $231.43M | +15.9% |
| FY2018 | Dec 31, 2018 | $199.68M | +74.3% |
| FY2017 | Dec 31, 2017 | $114.54M | -1.6% |
| FY2016 | Dec 31, 2016 | $116.41M | +11.0% |
| FY2015 | Dec 31, 2015 | $104.85M | +25.5% |
| FY2014 | Dec 31, 2014 | $83.57M | +56.9% |
| FY2013 | Dec 31, 2013 | $53.27M | -9.9% |
| FY2012 | Dec 31, 2012 | $59.10M | -43.4% |
| FY2011 | Dec 31, 2011 | $104.33M | -1.2% |
| FY2010 | Dec 31, 2010 | $105.57M | -26.3% |
| FY2009 | Dec 31, 2009 | $143.24M | +97.3% |
| FY2008 | Dec 31, 2008 | $72.59M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $95.98M | +134.6% |
| Q2 FY2026 | Jun 30, 2026 | $22.80M | +155.7% |
| Q1 FY2026 | Mar 31, 2026 | $9.80M | – |
| Q4 FY2025 | Dec 31, 2025 | $11.82M | -76.7% |
| Q3 FY2025 | Sep 30, 2025 | $40.91M | +81.9% |
| Q2 FY2025 | Jun 30, 2025 | $8.92M | -77.9% |
| Q1 FY2025 | Mar 31, 2025 | -$11.26M | -171.4% |
| Q4 FY2024 | Dec 31, 2024 | $50.74M | -13.6% |
| Q3 FY2024 | Sep 30, 2024 | $22.49M | -16.0% |
| Q2 FY2024 | Jun 30, 2024 | $40.40M | +42.9% |
| Q1 FY2024 | Mar 31, 2024 | $15.76M | -39.8% |
| Q4 FY2023 | Dec 31, 2023 | $58.75M | -31.2% |
| Q3 FY2023 | Sep 30, 2023 | $26.77M | -60.8% |
| Q2 FY2023 | Jun 30, 2023 | $28.28M | -57.5% |
| Q1 FY2023 | Mar 31, 2023 | $26.16M | -41.0% |
| Q4 FY2022 | Dec 31, 2022 | $85.33M | +23.2% |
| Q3 FY2022 | Sep 30, 2022 | $68.31M | -17.5% |
| Q2 FY2022 | Jun 30, 2022 | $66.48M | -27.2% |
| Q1 FY2022 | Mar 31, 2022 | $44.34M | -35.8% |
| Q4 FY2021 | Dec 31, 2021 | $69.28M | -13.7% |
| Q3 FY2021 | Sep 30, 2021 | $82.78M | +18.9% |
| Q2 FY2021 | Jun 30, 2021 | $91.29M | +175.7% |
| Q1 FY2021 | Mar 31, 2021 | $69.08M | +231.9% |
| Q4 FY2020 | Dec 31, 2020 | $80.26M | -10.0% |
| Q3 FY2020 | Sep 30, 2020 | $69.64M | +8.4% |
| Q2 FY2020 | Jun 30, 2020 | $33.12M | -31.8% |
| Q1 FY2020 | Mar 31, 2020 | $20.81M | -29.4% |
| Q4 FY2019 | Dec 31, 2019 | $89.18M | +108.9% |
| Q3 FY2019 | Sep 30, 2019 | $64.24M | -18.9% |
| Q2 FY2019 | Jun 30, 2019 | $48.52M | +34.0% |
| Q1 FY2019 | Mar 31, 2019 | $29.48M | -29.0% |
| Q4 FY2018 | Dec 31, 2018 | $42.69M | +269.6% |
| Q3 FY2018 | Sep 30, 2018 | $79.25M | +75.2% |
| Q2 FY2018 | Jun 30, 2018 | $36.21M | +25.4% |
| Q1 FY2018 | Mar 31, 2018 | $41.53M | +43.8% |
| Q4 FY2017 | Dec 31, 2017 | $11.55M | +76.9% |
| Q3 FY2017 | Sep 30, 2017 | $45.24M | – |
| Q2 FY2017 | Jun 30, 2017 | $28.87M | – |
| Q1 FY2017 | Mar 31, 2017 | $28.88M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.53M | – |
See a number that looks wrong?